PMEDF (QScreen AI) Ending Cash Position: $0.23 Mil (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is QScreen AI Ending Cash Position?

QScreen AI PMEDF +47.68% Ending Cash Position is $0.23 Mil as of Jan. 2026. The stock has 1 warning sign investors should review.

QScreen AI's Ending Cash Position for the quarter that ended in Jan. 2026 was $0.23 Mil.

QScreen AI's quarterly Ending Cash Position increased from Jul. 2025 ($0.09 Mil) to Oct. 2025 ($0.22 Mil) and increased from Oct. 2025 ($0.22 Mil) to Jan. 2026 ($0.23 Mil).

QScreen AI's annual Ending Cash Position declined from Jan. 2024 ($0.03 Mil) to Jan. 2025 ($0.00 Mil) but then increased from Jan. 2025 ($0.00 Mil) to Jan. 2026 ($0.23 Mil).

QScreen AI Ending Cash Position Related Terms

QScreen AI Ending Cash Position Historical Data

* Premium members only.

The historical data trend for QScreen AI's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QScreen AI Ending Cash Position Chart

QScreen AI Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Ending Cash Position
Get a 7-Day Free Trial 0.17 0.06 0.03 0.00 0.23

QScreen AI Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.21 0.09 0.22 0.23

QScreen AI Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

QScreen AI's Ending Cash Position for the fiscal year that ended in Jan. 2026 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=-8.3266726846887E-17+0.226
=0.23

QScreen AI's Ending Cash Position for the quarter that ended in Jan. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.228+-0.002
=0.23

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.23 Mil mean?
QScreen AI (PMEDF) has a Ending Cash Position of $0.23 Mil as of Jan. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on QScreen AI and its competitors.
Is QScreen AI's Ending Cash Position too high?
QScreen AI's current Ending Cash Position is $0.23 Mil.
How does QScreen AI's Ending Cash Position compare to ABT and SYK?
QScreen AI's Ending Cash Position of $0.23 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on QScreen AI and its competitors. QScreen AI's current Ending Cash Position is $0.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QScreen AI stock overvalued right now?
QScreen AI (PMEDF) has a current Ending Cash Position of $0.23 Mil. The current Ending Cash Position is $0.23 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For QScreen AI (PMEDF), the current Ending Cash Position is $0.23 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

QScreen AI Business Description

Other Exchanges 3QP:GermanyQAI:Canada
Address 40 King Street West, Suite 2400, P.O. Box 215, Scotia Plaza, Toronto, ON, CAN, M5H 3Y2
QScreen AI Inc is focused on developing artificial intelligence (AI) powered technologies for general workplace health and safety, and for the health care industry. The company's business is focused on artificial intelligence (AI) technologies targeting two specific areas: workplace health and safety and healthcare. It is building a proprietary artificial intelligence engine with quantum inspired computing and physiological sensing to clinical and occupational health assessments across correctional facilities, addiction medicine rehabilitation, and industrial workforce screening in multiple jurisdictions. It operates in single segment.